OFS
PRAX icon

OneAscent Financial Services’s Praxis Precision Medicines PRAX Stock Holding History

OneAscent Financial Services’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-704
Closed -$108K – 246
2022
Q1 		$108K Buy
+704
New +$145K 0.08% 140

Other funds holding PRAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

OneAscent Financial Services's PRAX Position: Q2 2022 in Review

OneAscent Financial Services sold out of Praxis Precision Medicines (PRAX) in Q2 2022, closing a stake of 704 shares — an estimated $108K sold.

OneAscent Financial Services first reported a position in PRAX in Q1 2022 and held it in 1 quarter. The position peaked at $108K in Q1 2022. 95 funds tracked by Wall St. Rank hold PRAX as of Q2 2022.

  • OneAscent Financial Services reported no remaining Praxis Precision Medicines position as of Q2 2022 after selling out during the quarter.
  • OneAscent Financial Services sold 704 Praxis Precision Medicines shares in Q2 2022, an estimated $108K.
  • OneAscent Financial Services first reported a position in Praxis Precision Medicines in Q1 2022 and held it in 1 quarter.
  • OneAscent Financial Services's Praxis Precision Medicines position peaked at $108K in Q1 2022.
  • 95 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2022.

Based on OneAscent Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.